Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 222

The DOI matches its Crossref record.

Randomized clinical trial of the effect of interferon α on survival in patients with disseminated midgut carcinoid tumours

Kölby, L, Persson, G, Franzén, S, Ahrén, B·2003·British Journal of Surgery

Abstract

Background: Midgut carcinoid tumours often present with widespread disease making curative surgery impossible. Medical treatment therefore plays a major role in the treatment of these patients. Methods: In this prospective randomized study, the effect of interferon (IFN) α on survival and risk of tumour progression was evaluated in 68 patients with midgut carcinoid tumours metastatic to the liver. All patients had undergone primary surgical treatment and hepatic arterial embolization of liver metastases before randomization. Patients were randomized to treatment with either octreotide alone (n = 35) or octreotide in combination with IFN-α (n = 33). Results: Forty-one of the 68 patients died during a follow-up period of 33–120 months, equivalent to a 5-year survival rate of 46·5 per cent. There was no significant difference in survival between patients treated with octreotide alone (5-year survival rate 36·6 per cent) and those given octreotide in combination with IFN-α (56·8 per cent). However, patients treated with IFN-α had a significantly reduced risk of tumour progression during follow-up (P = 0·008). Conclusion: Addition of IFN-α to octreotide may retard tumour growth in patients with midgut carcinoid tumours.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/bjs.4149

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Kölby, L., Persson, G., Franzén, S., & Ahrén, B.
Venue
British Journal of Surgery
Published
2003-06
Volume
90
Issue
6
Pages
687-693
ISSN
  • 0007-1323 (ISSN-L)
  • 1365-2168
OpenAlex
W2166417489
Cited by
222
References
0
FWCI
7.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.